Both tumors were reported as MSS from clinical testing and were hypermutated (POLD1/POLH tumor- 12.85 mut/Mb, POLE tumor- 14.44 mut/Mb) (Fig. 4B). The gene discussed is POLE; the disease is neoplasm.